The prevalence of androgenetic alopecia has not been accurately recorded but it is probably true that, at least in caucasoid races, some degree of transformation of terminal to vellus hair follicles on the vertex from puberty onwards is a universal phenomenon in both sexes, although androgenetic alopecia in women more often assumes a diffuse form. Our knowledge of the pathogenesis of ordinary baldness is far from complete but a genetic predisposition is necessary and androgen production must be present. In general it can be concluded that whatever the level of circulating androgens, free or total, the major genetic factor must reside in the end-organ response – in this case follicular receptivity and reactivity to the androgens delivered to the papilla/matrix unit. The pathophysiology of common baldness is strictly a misnomer as used in clinical practice since only rarely does it signify endocrine disease or other than normal physiological loss. In many patients the problem posed is essentially psychological and this aspect may be so predominant as to cause psychiatric disease.

Keywords:
Aetiology, Androgenetic alopecia, Clinical assessment, Nomenclature, Pathophysiology
This content is only available via PDF.
© 1987 S. Karger AG, Basel
1987
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.